BR9917367A - Método para preparação de citalopram e sua composição farmacêutica - Google Patents

Método para preparação de citalopram e sua composição farmacêutica

Info

Publication number
BR9917367A
BR9917367A BR9917367-0A BR9917367A BR9917367A BR 9917367 A BR9917367 A BR 9917367A BR 9917367 A BR9917367 A BR 9917367A BR 9917367 A BR9917367 A BR 9917367A
Authority
BR
Brazil
Prior art keywords
citalopram
preparation
pharmaceutical composition
compound
caino
Prior art date
Application number
BR9917367-0A
Other languages
English (en)
Inventor
Hans Petersen
Michael Harold Rock
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR9917367A publication Critical patent/BR9917367A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/847—Nickel

Abstract

"MéTODO PARA PREPARAçãO DE CITALOPRAM E SUA COMPOSIçãO FARMACêUTICA". Método para a preparação de citalopram compreendendo reação de um composto de Fórmula IV onde R é Cl ou Br na presença de um, catalisador de níquel e isolamento do composto 5-caino correspondente, ou seja, citalopram.
BR9917367-0A 1999-06-25 1999-11-19 Método para preparação de citalopram e sua composição farmacêutica BR9917367A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900921 1999-06-25
PCT/DK1999/000643 WO2000011926A2 (en) 1999-06-25 1999-11-19 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
BR9917367A true BR9917367A (pt) 2002-03-05

Family

ID=8099044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917367-0A BR9917367A (pt) 1999-06-25 1999-11-19 Método para preparação de citalopram e sua composição farmacêutica

Country Status (36)

Country Link
US (1) US6750358B2 (pt)
EP (1) EP1105382B1 (pt)
JP (1) JP3389571B2 (pt)
KR (1) KR100491369B1 (pt)
CN (1) CN1129593C (pt)
AR (1) AR020573A1 (pt)
AT (3) ATE213237T1 (pt)
AU (2) AU1374800A (pt)
BG (1) BG106190A (pt)
BR (1) BR9917367A (pt)
CA (1) CA2290125C (pt)
CH (1) CH691304A5 (pt)
CZ (1) CZ292174B6 (pt)
DE (2) DE19983486C2 (pt)
DK (1) DK1105382T3 (pt)
EA (1) EA002661B1 (pt)
ES (1) ES2172356T3 (pt)
FI (1) FI108538B (pt)
GB (1) GB2354240B (pt)
HK (1) HK1047745B (pt)
HU (1) HUP0103417A3 (pt)
IL (1) IL145960A0 (pt)
IS (1) IS5862A (pt)
IT (1) ITMI991579A1 (pt)
MX (1) MXPA01010986A (pt)
NO (1) NO20010318L (pt)
NZ (1) NZ514982A (pt)
PL (1) PL345971A1 (pt)
PT (1) PT1105382E (pt)
SE (1) SE516689C2 (pt)
SI (1) SI1105382T1 (pt)
SK (1) SK18412001A3 (pt)
TR (1) TR200103700T2 (pt)
UA (1) UA62023C2 (pt)
WO (1) WO2000011926A2 (pt)
ZA (1) ZA200108855B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512073A (en) 1998-12-23 2003-10-31 H Method for the preparation of 5-cyanophthalide and citalopram
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PT1173431E (pt) 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
DK1298124T3 (da) 1999-10-25 2007-07-09 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
GB2360281B (en) 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
EA004742B1 (ru) 1999-12-28 2004-08-26 Х.Лундбекк А/С Способ получения циталопрама
AU1858400A (en) 1999-12-30 2001-07-16 H. Lundbeck A/S Method for the preparation of citalopram
WO2001051477A1 (en) 2000-01-14 2001-07-19 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
KR20020080485A (ko) * 2000-03-13 2002-10-23 하. 룬트벡 아크티에 셀스카브 5-치환 1-(4-플루오로페닐)-1,3-디히드로이소벤조푸란의단계적 알킬화
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
TR200202166T2 (tr) 2000-03-13 2002-12-23 H. Lndbeck A/S Sitalopramın preparasyon metodu
TR200202155T2 (tr) 2000-03-14 2002-12-23 H. Lundbeck A/S Sitalopramin preparasyon metodu
WO2001068632A1 (en) * 2000-03-16 2001-09-20 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2383963A1 (en) * 2000-07-06 2002-01-17 Eva Bolzonella Method for the preparation of citalopram
CA2354880C (en) 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
TR200201166T1 (tr) * 2000-12-22 2002-10-21 H.Lundbecks A/S Saf sitalopram hazırlanması için yöntem
AU2001100399B4 (en) 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
CA2439856A1 (en) * 2001-03-09 2002-09-19 Swargam Sathyanarayana Process for the preparation of citalopram
EP1414435B1 (en) 2001-07-31 2005-01-12 H. Lundbeck A/S Crystalline composition containing escitalopram
WO2003057132A2 (en) 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
EP1797060A2 (en) 2004-08-23 2007-06-20 Sun Pharmaceutical Industries Limited "process for preparation of citalopram and enantiomers"
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (pt) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
CA2010159A1 (en) 1989-02-21 1990-08-21 James J. Maul Cyanation of haloaromatics utilizing catalysts generated in situ starting with nic1 or nic1 6h 0
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19706648A1 (de) 1997-02-20 1998-08-27 Bayer Ag Verfahren zur Herstellung von aromatischen Nitrilen
SK283309B6 (sk) 1997-07-08 2003-05-02 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
EP1042310B1 (en) 1997-11-11 2002-07-31 H. Lundbeck A/S Method for the preparation of citalopram
ES2189502T3 (es) 1998-10-20 2003-07-01 Lundbeck & Co As H Metodo para la prevencion de citalopram.
NZ512073A (en) 1998-12-23 2003-10-31 H Method for the preparation of 5-cyanophthalide and citalopram
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
US6331628B1 (en) 1999-03-29 2001-12-18 Nissan Chemical Industries, Ltd. Process for the preparation of benzonitrile compounds
PT1173431E (pt) 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
GB2360281B (en) 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
TR200201166T1 (tr) 2000-12-22 2002-10-21 H.Lundbecks A/S Saf sitalopram hazırlanması için yöntem
AU2001100399B4 (en) 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram

Also Published As

Publication number Publication date
US6750358B2 (en) 2004-06-15
CZ292174B6 (cs) 2003-08-13
JP2002523432A (ja) 2002-07-30
UA62023C2 (en) 2003-12-15
GB2354240B (en) 2001-05-23
AU1374800A (en) 2000-03-21
CN1129593C (zh) 2003-12-03
IS5862A (is) 2001-02-23
NO20010318D0 (no) 2001-01-19
US20020061925A1 (en) 2002-05-23
CH691304A5 (de) 2001-06-29
NO20010318L (no) 2001-02-20
DE69900891D1 (de) 2002-03-21
ITMI991579A0 (it) 1999-07-15
AT4366U1 (de) 2001-06-25
EP1105382B1 (en) 2002-02-13
SI1105382T1 (en) 2002-06-30
CA2290125A1 (en) 2000-12-25
HUP0103417A2 (hu) 2002-01-28
JP3389571B2 (ja) 2003-03-24
ATE213237T1 (de) 2002-02-15
SE0100194D0 (sv) 2001-01-24
AU2001100433B4 (en) 2002-01-17
DK1105382T3 (da) 2002-05-27
DE19983486T1 (de) 2001-10-18
GB0101508D0 (en) 2001-03-07
EA002661B1 (ru) 2002-08-29
BG106190A (en) 2002-08-30
PL345971A1 (en) 2002-01-14
ZA200108855B (en) 2002-08-28
EP1105382A2 (en) 2001-06-13
FI20010154A (fi) 2001-02-09
GB2354240A (en) 2001-03-21
SE516689C2 (sv) 2002-02-12
HK1047745A1 (en) 2003-03-07
ITMI991579A1 (it) 2001-01-15
AR020573A1 (es) 2002-05-15
NZ514982A (en) 2004-01-30
MXPA01010986A (es) 2002-06-04
PT1105382E (pt) 2002-07-31
KR20020011982A (ko) 2002-02-09
ES2172356T3 (es) 2002-09-16
AU2001100433A4 (en) 2001-11-01
EA200101071A1 (ru) 2002-02-28
CZ2001319A3 (en) 2001-05-16
HUP0103417A3 (en) 2003-01-28
TR200103700T2 (tr) 2002-05-21
FI108538B (fi) 2002-02-15
AT409960B (de) 2002-12-27
WO2000011926A3 (en) 2000-06-29
CN1356993A (zh) 2002-07-03
WO2000011926A2 (en) 2000-03-09
HK1047745B (zh) 2004-09-10
SK18412001A3 (sk) 2002-05-09
IL145960A0 (en) 2002-07-25
KR100491369B1 (ko) 2005-05-24
DE19983486C2 (de) 2002-09-05
CA2290125C (en) 2004-08-10
ATA904099A (de) 2002-05-15
SE0100194L (sv) 2001-04-25

Similar Documents

Publication Publication Date Title
BR9917367A (pt) Método para preparação de citalopram e sua composição farmacêutica
BR0108947A (pt) Método para preparação e citalopram; intermediário e sua composição farmacêutica
BR0111667A (pt) Novos compostos
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
BR9804815A (pt) "composições antimicrobianas"
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
BR0108679A (pt) Novos compostos
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
ZA9710796B (en) Oxyiminopregnanecarbolactones.
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
ES2189489T3 (es) Uso de derivados n-acilvainillinamidicos como agonistas de receptores cb1 perifericos de cannabinoides.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
SE8904298D0 (sv) New compounds
BR0109022A (pt) Método de preparação de citalopram e sua composição farmacêutica
BR0111669A (pt) Novos compostos
BR0110996A (pt) Método para preparação de citalopram; composto; intermediário e, sua composição farmacêutica
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
PT1000067E (pt) Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.
BR9913601A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para a preparação de compostos
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
ES2178080T3 (es) Procedimiento para la preparacion de derivados de alcoxi-o ariloxi-pirazina.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.